Syndax Pharmaceuticals, Inc. (SNDX) — Analysis Summary
Syndax Pharmaceuticals, Inc. (SNDX) has a market cap of $1.69B with year-over-year revenue growth of +627.8%. Net margin stands at -165.6%. The stock trades at a P/E ratio of -6.9.
Key Takeaways
- Revenue changed +627.8% year-over-year
- Net margin of -165.6%
- P/E ratio of -6.9
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, SNDX posted revenue growth of +627.8% and trades at a P/E of -6.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.